Pages that link to "Q36444282"
Jump to navigation
Jump to search
The following pages link to Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review (Q36444282):
Displaying 50 items.
- Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy (Q24629542) (← links)
- A new view of carcinogenesis and an alternative approach to cancer therapy (Q24650249) (← links)
- Lung cancer in never smokers (Q28386853) (← links)
- A gene expression signature predicts survival of patients with stage I non-small cell lung cancer (Q28764568) (← links)
- Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma (Q30409463) (← links)
- A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma (Q31018336) (← links)
- Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children (Q33553382) (← links)
- Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. (Q33652512) (← links)
- Epidemiology of lung cancer prognosis: quantity and quality of life (Q34135295) (← links)
- Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients (Q34160556) (← links)
- Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study (Q34385453) (← links)
- The resurgence of platinum-based cancer chemotherapy (Q34649255) (← links)
- RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy (Q34759878) (← links)
- Copy number variants in pharmacogenetic genes (Q34975631) (← links)
- Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy (Q35072797) (← links)
- xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases (Q35099427) (← links)
- Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients. (Q35100937) (← links)
- Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy (Q35121648) (← links)
- Systematic Evaluation of Genetic Variants in Three Biological Pathways on Patient Survival in Low-Stage Non-small Cell Lung Cancer (Q35171191) (← links)
- Genetic and epigenetic regulation of gene expression in fetal and adult human livers (Q35302040) (← links)
- PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer. (Q35678113) (← links)
- Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer (Q36148775) (← links)
- A bioactive probe of the oxidative pentose phosphate cycle: novel strategy to reverse radioresistance in glucose deprived human colon cancer cells (Q36442296) (← links)
- A functional trinucleotide repeat polymorphism in the 5'-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers. (Q36677916) (← links)
- Functional significance of the GAG trinucleotide-repeat polymorphism in the gene for the catalytic subunit of gamma-glutamylcysteine ligase. (Q36924430) (← links)
- The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione (Q37101259) (← links)
- Identifying reproducible cancer-associated highly expressed genes with important functional significances using multiple datasets (Q37379617) (← links)
- Genetic variations as cancer prognostic markers: review and update (Q37565360) (← links)
- A bioactive probe for glutathione-dependent antioxidant capacity in breast cancer patients: implications in measuring biological effects of arsenic compounds (Q37625524) (← links)
- Identification of glyceollin metabolites derived from conjugation with glutathione and glucuronic acid in male ZDSD rats by online liquid chromatography-electrospray ionization tandem mass spectrometry (Q37697416) (← links)
- An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs. (Q37939200) (← links)
- Targeting and delivery of platinum-based anticancer drugs (Q38050063) (← links)
- Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosing (Q38186660) (← links)
- A paradoxical chemoresistance and tumor suppressive role of antioxidant in solid cancer cells: a strange case of Dr. Jekyll and Mr. Hyde (Q38209675) (← links)
- Genetic variations underlying self-reported physical functioning: a review (Q38267213) (← links)
- Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer (Q39490189) (← links)
- Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil. (Q39837066) (← links)
- Characterizing DNA methylation patterns in pancreatic cancer genome. (Q39842549) (← links)
- Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R). (Q39980204) (← links)
- Insights from the Molecular Docking of Hydrolytic Products of Methyl Isocyanate (MIC) to Inhibition of Human Immune Proteins. (Q41038973) (← links)
- Insights from the molecular docking of hydrolytic products of methyl iso cyanate (MIC) to inhibition of human immune proteins (Q41540304) (← links)
- In silico interaction of methyl isocyanate with immune protein responsible for Mycobacterium tuberculosis infection using molecular docking. (Q41967031) (← links)
- Oxidative stress in non-small cell lung cancer: role of nicotinamide adenine dinucleotide phosphate oxidase and glutathione (Q46077692) (← links)
- The Cystine/Cysteine Cycle and GSH Are Independent and Crucial Antioxidant Systems in Malignant Melanoma Cells and Represent Druggable Targets (Q54375649) (← links)
- Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells. (Q55261457) (← links)
- "Platinum on the road": Interactions of antitumoral cisplatin with proteins (Q59172548) (← links)
- Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling (Q64113597) (← links)
- Identification of key pathways and genes in lung carcinogenesis. (Q64941057) (← links)
- The Role of NF-E2-Related Factor 2 in Predicting Chemoresistance and Prognosis in Advanced Non–Small-Cell Lung Cancer (Q84334523) (← links)
- [Complementary medicine in oncology] (Q84750588) (← links)